Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New York for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New York only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New York (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Paul Hahn (NPI 1043360704)

Field	Value
Entity Type	Individual
Organization	Paul Hahn
Address	25 Smith St Ste 414
City	Nanuet
State	NY
ZIP	10954
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	January 12, 2007

Payer Source	Total Paid
Medicare	$3.1M
Medicaid	$0

Key Findings

This provider is a retina-focused ophthalmology practice with a procedural mix dominated by intravitreal biologic injections and retinal imaging. The top Medicare codes are J0178 (aflibercept injection), J2778/J2777 (ranibizumab and faricimab injections), and high-volume retinal imaging codes (92134), which together indicate the practice primarily delivers physician-administered anti-VEGF and related therapies and follows patients with diagnostic OCT imaging and other retinal exams. The code set and descriptions point to a treatment workflow centered on recurrent office-based injections and monitoring of retinal disease.

Medicare revenue is concentrated in a very small number of high-value drug and procedure codes: the precomputed top-three codes account for 68.4% of the provider’s total Medicare revenue, and J0178 alone generates $1.4M (45.1% of total Medicare revenue). This concentration implies business and reimbursement risk is tied to continued demand for and reimbursement of intravitreal anti-VEGF agents.

This provider effectively operates as a single-payer Medicare-dependent practice with $3.1M in lifetime Medicare revenue and no Medicaid billing on file; the absence of Medicaid activity means payer mix lacks state-program diversification and the provider’s revenue profile and patient volume are driven entirely by Medicare.

Competitive standing on Medicare for key injection and imaging codes is mixed: for J0178 the provider ranks #528 of 3204 (84th percentile), and for J2778 ranks #187 of 1208 (85th percentile), placing them as a solid, above-typical national participant for commonly used anti-VEGF agents rather than a dominant national leader. In contrast, for office-based comprehensive exam 92014 the provider ranks #92 of 35415 (100th percentile) and for OCT 92134 ranks #515 of 26868 (98th percentile), indicating exceptional volume in these services relative to national peers and a strong practice footprint for follow-up and diagnostic management.

Several CPT/HCPCS entries are statistical outliers in national volume: 92014 is labeled an "extreme outlier, far above typical national volume," 92134 is also an "extreme outlier, far above typical national volume," and 92202 is similarly an "extreme outlier, far above typical national volume." These unusually high volumes for comprehensive exams and extended ophthalmoscopy suggest a large established Medicare patient panel managed longitudinally, with frequent monitoring and documentation of retinal disease.

The provider has an established NPI with enumeration dating to 2007-01-12 (~19 years ago), indicating long tenure in the Medicare program. This duration supports the observed high cumulative Medicare revenue ($3.1M) and sustained service lines (repeated injections and imaging) rather than a recent escalation in billing.

Routine ancillary codes and some unclassified drug/biologic codes (J3590, J3490, J7999) show modest contribution to revenue ($95.4K, $86.6K, and $8.9K respectively) and fall in mid-to-lower national percentiles, suggesting occasional or lower-volume use of nonstandard or compounded agents alongside the primary anti-VEGF treatments rather than a core business line.

Procedure-level economics show different revenue-per-claim profiles: high-cost biologics such as J0178 average $693 paid/claim and drive the largest portion of revenue, whereas imaging and injection procedure codes (e.g., 92014, 67028, 92134) have much lower per-claim payments but high claim counts, reflecting a model that mixes infrequent high-dollar drug reimbursements with frequent, lower-paid visits and diagnostics to manage chronic retinal disease.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,020	$690	$1.4M
J2778	Injection, ranibizumab, 0.1 mg	2,250	$190	$423K
J2777	Injection, faricimab‑svoa, 0.1 mg	10,440	$30	$302.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	2,710	$110	$284.7K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,820	$110	$190.9K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	710	$220	$151.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,760	$40	$99.2K
J3590	Unclassified biologics	40	$2,330	$95.4K
J3490	Unclassified drugs	50	$1,770	$86.6K
92202	The provider performs an extended ophthalmoscopy, typically with an indirect ophthalmoscope which utilizes a bright light and a hand–held indirect lens rather than the common hand–held one–piece…	1,780	$10	$23.1K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New York Distribution

Paul Hahn — 5 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New York

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	9	230	560	$690	$693K
J2777	25	120	7,740	$30	$364.9K
Q5128	6	20	1,170	$220	$268.3K
J2778	8	70	510	$180	$131.6K
J3590	16	20	30	$1,430	$72.7K
67028	12	300	400	$100	$65.9K
J3490	69	120	60	$470	$50.8K
92014	9	2,220	160	$100	$29.3K
92012	589	1,640	100	$70	$17.4K
92235	48	190	60	$120	$14.1K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with Paul Hahn, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Associated Retinal Consultants LLC	DE	Ophthalmology Physician	$0	$25.2M
Rohit Lakhanpal	MD	Retina Specialist (Ophthalmology) Physician	$6.1M	$0
Vinod Voleti	NJ	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Sumit Shah	NJ	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Newman Sund	MD	Ophthalmology Physician	$4M	$0
Eric Suan	MD	Ophthalmology Physician	$3.8M	$0
Matthew Speicher	MD	Ophthalmology Physician	$3.7M	$0
Howard Fine	NJ	Retina Specialist (Ophthalmology) Physician	$3.6M	$0
Timothy Polk	MD	Ophthalmology Physician	$3.5M	$0
Jonathan Prenner	NJ	Retina Specialist (Ophthalmology) Physician	$3.4M	$0

Nearby Providers

Other providers in the same ZIP code as Paul Hahn, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Rockland Mobile Care, Inc.	NY	Land Ambulance	$748.6K	$4.2M
Harinder Gill	NY	Internal Medicine Physician	$216.4K	$76.1K
Jay Levine	NY	Podiatrist	$156K	$18.4K
Bardonia Pharmacy LLC	NY	Community/Retail Pharmacy	$118.6K	$0

Paul Hahn — Billing Profile & Reimbursement Data

Sign up for Paul Hahn — Billing Profile & Reimbursement Data policy alerts

Paul Hahn — Billing Profile & Reimbursement Data

Sign up for Paul Hahn — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References